• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[适合肺癌化疗的条件]

[Conditions suitable for chemotherapy of lung cancer].

作者信息

Fukuoka M, Takada M, Negoro S, Tamai S, Matsui K, Sakai N, Ryu S, Yoshinaga T

出版信息

Gan No Rinsho. 1983 Aug;29(10):1223-8.

PMID:6313983
Abstract

The influence of several factors for response to Chemotherapy and survival was analysed in 310 patients with inoperable lung cancer who were treated by single or combination chemotherapy. In small cell lung cancer, survival was strongly affected by the results of induction chemotherapy, and combination chemotherapy with three or four drugs was most effective. In non-small cell lung cancer, performance status and body weight loss on admission were important factors for response to chemotherapy and survival. Combinations did not improve the response rate in non-small cell lung cancer.

摘要

对310例无法手术的肺癌患者进行了单药或联合化疗,分析了几个因素对化疗反应和生存的影响。在小细胞肺癌中,诱导化疗结果对生存有强烈影响,三药或四药联合化疗最为有效。在非小细胞肺癌中,体能状态和入院时体重减轻是化疗反应和生存的重要因素。联合用药并未提高非小细胞肺癌的缓解率。

相似文献

1
[Conditions suitable for chemotherapy of lung cancer].[适合肺癌化疗的条件]
Gan No Rinsho. 1983 Aug;29(10):1223-8.
2
[Cisplatin, peplomycin, mitomycin C, and vincristine combination chemotherapy of non-small cell carcinoma of the lung].[顺铂、培普利欧霉素、丝裂霉素C与长春新碱联合化疗治疗非小细胞肺癌]
Gan To Kagaku Ryoho. 1984 Dec;11(12 Pt 2):2715-8.
3
[Combination chemotherapy with cis-platinum, adriamycin and mitomycin C (PAM) in the treatment of non-small cell carcinoma of the lung].顺铂、阿霉素和丝裂霉素C联合化疗(PAM)治疗非小细胞肺癌
Gan To Kagaku Ryoho. 1986 Jun;13(6):2123-7.
4
[Current status in the treatment of inoperable non-small cell lung cancer (NSCLC)].[不可切除非小细胞肺癌(NSCLC)的治疗现状]
Gan To Kagaku Ryoho. 1985 Jan;12(1):54-60.
5
Induction chemotherapy in non small cell lung cancer stage IIIa-b and IV and second-line treatment.非小细胞肺癌 IIIa-b 期和 IV 期的诱导化疗及二线治疗。
Anticancer Res. 1999 Jul-Aug;19(4C):3543-8.
6
Survival and prognostic factors in lung cancer patients treated in phase I trials: Japanese experience.肺癌患者在I期试验中的生存及预后因素:日本经验
Int J Oncol. 1999 Oct;15(4):737-41.
7
[Postoperative chemotherapy of pathological stage I non-small cell carcinoma of the lung].
Gan To Kagaku Ryoho. 1986 Jan;13(1):24-9.
8
Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.小细胞肺癌的化疗:格林莱恩医院1993 - 1995年的经验
N Z Med J. 1998 Nov 27;111(1078):451-2, 453-4.
9
Influence of smoking on histologic type and the efficacy of adjuvant chemotherapy in resected non-small cell lung cancer.吸烟对切除的非小细胞肺癌组织学类型及辅助化疗疗效的影响。
Lung Cancer. 2008 Jun;60(3):434-40. doi: 10.1016/j.lungcan.2007.10.013. Epub 2007 Nov 26.
10
[Treatment of lung cancer by a cooperative group: EORTC Lung Cancer Working Party (Belgium)].
Rev Med Brux. 1983 Sep;4(7):485-9.